cimetidine has been researched along with Papilloma, Squamous Cell in 6 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Excerpt | Relevance | Reference |
---|---|---|
"To describe a case of recurrent, advanced conjunctival papillomatosis, treated by oral cimetidine (CIM) combined with secondary surgical intervention and an application of intraoperative mitomycin C." | 7.73 | Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis. ( Chang, SW; Huang, ZL, 2006) |
"To report the efficacy of cimetidine for treatment of conjunctival papillomatosis." | 7.70 | Oral cimetidine (Tagamet) for recalcitrant, diffuse conjunctival papillomatosis. ( Lally, MR; Nowinski, T; Shields, CL; Shields, JA; Singh, AD, 1999) |
"To describe a case of recurrent, advanced conjunctival papillomatosis, treated by oral cimetidine (CIM) combined with secondary surgical intervention and an application of intraoperative mitomycin C." | 3.73 | Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis. ( Chang, SW; Huang, ZL, 2006) |
"To report the efficacy of cimetidine for treatment of conjunctival papillomatosis." | 3.70 | Oral cimetidine (Tagamet) for recalcitrant, diffuse conjunctival papillomatosis. ( Lally, MR; Nowinski, T; Shields, CL; Shields, JA; Singh, AD, 1999) |
"Conjunctival papilloma is a benign epithelial tumor occurring in both children and adults with varying clinical features and outcomes." | 1.39 | Conjunctival papilloma: features and outcomes based on age at initial examination. ( Arepalli, S; Hysenj, E; Kaliki, S; Klein, K; Lally, SE; Shields, CL; Shields, JA; Sun, H, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaliki, S | 1 |
Arepalli, S | 1 |
Shields, CL | 2 |
Klein, K | 1 |
Sun, H | 1 |
Hysenj, E | 1 |
Lally, SE | 1 |
Shields, JA | 2 |
Chang, SW | 1 |
Huang, ZL | 1 |
Lally, MR | 1 |
Singh, AD | 1 |
Nowinski, T | 1 |
Harcourt, JP | 1 |
Worley, G | 1 |
Leighton, SE | 1 |
Fischer, SM | 1 |
Patrick, KE | 1 |
Patamalai, B | 1 |
Slaga, TJ | 1 |
Spinowitz, A | 1 |
Rumsfield, J | 1 |
1 review available for cimetidine and Papilloma, Squamous Cell
Article | Year |
---|---|
Cimetidine treatment for recurrent respiratory papillomatosis.
Topics: Adjuvants, Immunologic; Bronchial Neoplasms; Child; Cimetidine; Female; Follow-Up Studies; Humans; I | 1999 |
5 other studies available for cimetidine and Papilloma, Squamous Cell
Article | Year |
---|---|
Conjunctival papilloma: features and outcomes based on age at initial examination.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Child; Child, Preschool; Cimetidine; Combin | 2013 |
Oral cimetidine adjuvant therapy for recalcitrant, diffuse conjunctival papillomatosis.
Topics: Administration, Oral; Alkylating Agents; Child; Cimetidine; Combined Modality Therapy; Conjunctival | 2006 |
Oral cimetidine (Tagamet) for recalcitrant, diffuse conjunctival papillomatosis.
Topics: Adjuvants, Immunologic; Administration, Oral; Child; Cimetidine; Conjunctival Neoplasms; Humans; Mal | 1999 |
Effects of antihistamines on phorbol ester tumor promotion and vascular permeability changes.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Capillary Permeability; Cimetidine; Diphenhydramine; Fema | 1990 |
Immunologic enhancers.
Topics: Adjuvants, Immunologic; Cimetidine; Conjunctival Neoplasms; Humans; Papilloma | 1987 |